Clemens R. Scherzer, M.D.
Assistant Professor of Neurology
Harvard Medical School
Harvard NeuroDiscovery Biomarker Program
Brigham and Women's Hospital
Massachusetts General Hospital
To cure Parkinson’s disease new drugs and diagnostics are needed. We look at a global view of gene activity in human Parkinson’s disease to discover disease genes, drug targets, and molecular biomarkers. We integrate large scale clinical studies with genome-wide expression analysis and genetic validation in Parkinson’s and other neurodegenerative diseases.
Study: Brain 'energy crisis' may spark Parkinson's
USAToday, November 3, 2010 »more
Study links Parkinson’s to brain’s tiny power factories
November 2, 2010 »more
Damaged cell powerhouses linked to Parkinson's
Nature, October 6, 2010 »more
Gene Captain, PGC-1α, Abandons Mitochondria in PD
Alzheimer Research Forum, October 2010 »more
Transcriptional regulation of α-synuclein: insights from blood?
Future Neurology, March 2009 »more
Interview - Searching for biomarkers in Parkinson's disease
Biomarkers in Medicine, April, 2009 »more